PGNX

Progenics Pharmaceuticals Inc
PGNX

Overview Fund Activity
Delisted

PGNX was delisted on the 19th of June, 2020.

Back to rankings

104 hedge funds and large institutions have $249M invested in Progenics Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 29 closing their positions.

Holders
104
Holders Change
-16
Holders Change %
-13.33%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
31
Reduced
33
Closed
29
Calls
$334K
Puts
$2.47M
Net Calls
-$2.14M
Net Calls Change
-$2.04M

Top Buyers

1
PA
1
Pinnacle Associates
New York
$12M
2
AAP
2
Ardsley Advisory Partners
Connecticut
$1.69M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$11.6M
4
ACP
4
Acuta Capital Partners
California
$1.89M
5
Deutsche Bank
5
Deutsche Bank
Germany
$1.19M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$14.1M
2
Millennium Management
2
Millennium Management
New York
$9.55M
3
BBA
3
Baker Bros. Advisors
New York
$16.8M
4
GCP
4
GSA Capital Partners
United Kingdom
$55K
5
PCM
5
Piermont Capital Management
Missouri
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
126
Barclays
United Kingdom
– – -11,892 Closed
D.E. Shaw & Co
127
D.E. Shaw & Co
New York
– – -11,552 Closed
Simplex Trading
128
Simplex Trading
Illinois
– – -6,018 Closed
ST
129
Spot Trading
Illinois
– – -1,400 Closed
TRCT
130
Tower Research Capital (TRC)
New York
– – -554 Closed
Bessemer Group
131
Bessemer Group
New Jersey
– – -344 Closed
PA
132
Perceptive Advisors
New York
– – – –
MSFP
133
Mark Sheptoff Financial Planning
Connecticut
$0 10 – –
PRS
134
Pinkerton Retirement Specialists
Idaho
$0 80 +80 New
2 3 4 5
6